US Stock MarketDetailed Quotes

JSPR Jasper Therapeutics

Watchlist
  • 22.730
  • +0.680+3.08%
Close Nov 25 16:00 ET
  • 23.500
  • +0.770+3.39%
Post 20:01 ET
340.98MMarket Cap-4785P/E (TTM)

Jasper Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jasper Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Jasper Therapeutics Earnings Reports

  • 8-K: Jasper Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 7 07:43 ET

  • 10-Q: Q3 2024 Earnings Report

    Nov 7 07:33 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 13 07:02 ET

  • 10-Q: Q1 2024 Earnings Report

    May 14 13:55 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 7, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data